BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30828837)

  • 1. Clonal highlights: Clonal seborrheic keratoses often demonstrates p16 expression.
    Omman RA; Speiser J; Robinson S; Lapadat R; Mudaliar K
    J Cutan Pathol; 2019 Jun; 46(6):411-417. PubMed ID: 30828837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Seborrheic Keratosis Versus Pagetoid Bowen Disease: Histopathology and Role of Adjunctive Markers.
    Kalegowda IY; Böer-Auer A
    Am J Dermatopathol; 2017 Jun; 39(6):433-439. PubMed ID: 28475506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease From "Microclonal" Seborrheic Keratosis.
    Bahrani E; Sitthinamsuwan P; McCalmont TH; Pincus LB
    Am J Clin Pathol; 2019 May; 151(6):551-560. PubMed ID: 30852607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
    Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
    Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.
    Böer-Auer A; Jones M; Lyasnichaya OV
    J Cutan Pathol; 2012 Feb; 39(2):225-33. PubMed ID: 22236073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "intraepidermal epithelioma" revisited: immunohistochemical study of the borst-jadassohn phenomenon.
    Lora V; Chouvet B; Kanitakis J
    Am J Dermatopathol; 2011 Jul; 33(5):492-7. PubMed ID: 21587033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
    Auepemkiate S; Thongsuksai P; Boonyaphiphat P
    J Med Assoc Thai; 2006 Sep; 89(9):1460-5. PubMed ID: 17100385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its association with human papillomavirus infection.
    Wu YH; Hsiao PF; Chen CK
    Am J Dermatopathol; 2015 Jun; 37(6):462-8. PubMed ID: 25747812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
    Genders RE; Beck S; Bouwes Bavinck JN; van den Munckhof HA; Kouwenhoven ST; de Koning MN; de Gruijl FR; Jenkins D; Willemze R; Quint KD
    J Cutan Pathol; 2017 Jan; 44(1):28-33. PubMed ID: 27717097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
    Ko C; Srisuttiyakorn C
    J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L; Cuevas J; Juarranz A
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eccrine porocarcinoma and Bowen's disease arising in a seborrhoeic keratosis.
    Hoshina D; Akiyama M; Hata H; Aoyagi S; Sato-Matsumura KC; Shimizu H
    Clin Exp Dermatol; 2007 Jan; 32(1):54-6. PubMed ID: 17004985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease.
    Murao K; Yoshioka R; Kubo Y
    J Dermatol; 2014 Oct; 41(10):878-84. PubMed ID: 25201325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle cell squamous cell carcinoma arising in Bowen's disease: Case report and review of the published work.
    Kogame T; Tanimura H; Nakamaru S; Makimura K; Okamoto H; Kiyohara T
    J Dermatol; 2017 Sep; 44(9):1055-1058. PubMed ID: 28370387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.